Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingfei Xiaoyan Wan (concentrated pill) in acute and acute exacerbation of chronic bronchitis
CTR20132051Phase 2Suspended
- Sponsor
- Tianjin Pharmaceutical Da Ren Tang Group Corp., Ltd.
- Start
- Jan 2014
- Countries
- 1
01
Overview
A Phase 2 trial of Qingfei Xiaoyan Wan in acute bronchitis, chronic bronchitis (CB), sponsored by Tianjin Pharmaceutical Da Ren Tang Group Corp., Ltd.. Started Jan 2014; status: suspended.
02
Drugs
Qingfei Xiaoyan Wan
03
Conditions
acute bronchitischronic bronchitis (CB)
Beyond the preview
Go deeper on CTR20132051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132051.